Search

This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the the period 26 June-2 July 2022 and includes updates on West Nile virus infection, COVID-19, hepatitis, monkeypox, plague, dengue, polio, chikungunya and cholera.

This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the the period 12-18 June 2022 and includes updates on West Nile virus infection, COVID-19, hepatitis, monkeypox, Mycobacterium chelonae in bioprosthetic heart valves and influenza.

This report presents findings related to the hepatitis B and C continuum of care, policy on testing and treatment, and the impact of the COVID-19 pandemic on hepatitis services in the EU/EEA from the second data collection conducted in 2021.

This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 5-11 June 2022 and includes updates on West Nile virus infection, COVID-19, hepatitis, monkeypox, measles and MERS-CoV.

This document provides guidance on diagnostic testing, molecular characterisation and metagenomic analysis for suspect cases of severe acute hepatitis of unknown aetiology.

This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 15-21 May 2022 and includes updates on COVID-19, the arrival of people displaced from Ukraine to the EU following Russia's invasion of Ukraine, Influenza, polio virus, hepatitis, avian influenza, swine influenza, and poliomyelitis.

This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 8-14 May 2022 and includes updates on COVID-19, Influenza, the arrival of people displaced from Ukraine to the EU following Russia's invasion of Ukraine, hepatitis, measles and monkeypox.

This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 1-7 May 2022 and includes updates on COVID-19, Influenza, the arrival of people displaced from Ukraine to the EU following Russia's invasion of Ukraine, hepatitis, Ebola, Middle East respiratory syndrome coronavirus, chikungunya and dengue.

This reporting protocol is intended for reporting national case-based data for surveillance of hepatitis of unknown origin from all the countries and areas of the WHO European Region, including the 27 countries of the European Union (EU) and the additional three countries of the European Economic Area (EEA), to the European level.

An increase in severe acute hepatitis cases of unknown aetiology among previously healthy children was first reported by the United Kingdom (UK) on 5 April 2022.